通过SLC39A8介导的双体平衡增强了脏疾病的潜力
Zhaoxian Cai1,2,3, Xiaotian Wu1, Tianyi Wang3
1The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou 310058, China.
概括
在SLC39A8中有一个共享的遗传变异改变了病风险. 准脏积和恒常性提供了一个新的治疗策略,用于各种病理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 许多遗传风险位与脏疾病有关,但缺乏普遍的治疗点.
- 编码载体的SLC39A8基因参与了各种细胞过程.
- 了解特定遗传变异在病理中的作用对于开发向疗法至关重要.
研究的目的:
- 为了确定多种脏疾病的共享基因修饰剂.
- 研究SLC39A8 A391T变异在病理中的功能作用.
- 阐明平衡影响病进展的机制.
主要方法:
- 大队列多态位点查以识别遗传变异.
- 使用Slc39a8 A391T敲门和脏特异性敲门小鼠模型进行功能性表征.
- 评估的水平,损伤标志物和疾病进展,以应对改变的SLC39A8功能和化.
主要成果:
- 鉴定出SLC39A8 A391T变种 (rs13107325) 是多种脏疾病的共同修饰者.
- 在小鼠中,SLC39A8功能的丧失减少了在脏中的积累,减轻了损伤和疾病进展.
- 打乱的平衡被证明可以驱动损伤,而限制水平可以激活保护信号轴 (zinc-AKT-FOXO1-G6PC).
- 用EDTA化有效地预防和改善了实验中的急性和慢性病.
结论:
- 在脏的平衡是脏疾病的关键治疗标.
- SLC39A8基因和调节水平的策略代表了有前途的治疗途径.
- 针对积累提供了一个统一的方法,用于各种病理.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:24Renal Tubule and Collecting Duct
3.2K
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
3.2K
01:24Chronic Kidney Disease II: Clinical Manifestations
557
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557
01:28Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
1.6K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.6K
01:11Renal Failure: Dose Adjustments
438
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
438